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Abstract: 
Objectives: Dental caries and periodontal diseases are caused by infection of teeth and 
supporting tissues due to complex aggregate of bacteria known as biofilm, firstly colonized 
by streptococci. The main purpose of this in vitro study was to evaluate the antimicrobial 
effects of toluidine blue O (TBO) and Radachlorin® in combination with a diode laser on 
the viability of Streptococcus mutans. 
Materials and Methods: Bacterial suspensions of Streptococcus mutans were exposed to 
either 0.1% TBO associated with (20 mW, 633 nm diode laser, continuous mode, 150 s) or 
0.1% Radachlorin® and laser irradiation (100 mW, 662 nm diode laser, continuous mode, 
120  s).  Those  in  control  groups  were  subjected  to  laser  irradiation  alone  or 
TBO/Radachlorin® alone or received neither TBO/Radachlorin® nor laser exposure. The 
suspensions were then spread over specific agar plates and incubated aerobically at 37°C. 
Finally, the bactericidal effects were evaluated based on colony formation. 
Results:  Potential  bacterial  cell  killing  was  only  observed  following  photosensitization 
with TBO and 3 j/cm
2 laser exposure (p<0.05), whereas Radachlorin® showed significant 
reduction in dark condition compared to laser exposure (p<0.05). 
Conclusion: TBO-mediated photodynamic therapy seems to be more efficient than Ra-
dachlorin® in significantly reducing the viability of Streptococcus mutans in vitro. 
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INTRODUCTION 
The human oral cavity is colonized by a highly 
diverse  community  of  bacteria.  Most  of  the 
bacteria existing in the oral cavity are present 
as complex aggregates known as biofilms on 
the surfaces of the teeth and these biofilms are 
termed “dental plaques” [1-2]. Streptococci are 
said to be the first bacteria which colonize in 
oral surfaces and may consist 70% of the cul-
tivable  bacteria  existing  in  the  human  dental 
plaque and Streptococcus mutans as the primry 
odontopathogen presents in the supragingival Journal of Dentistry, Tehran University of Medical 
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plaque and results in one kind of oral disease 
known as dental caries [3-4].  
Since both dental caries and periodontal dis-
ease start initially by plaque accumulation on 
the  oral  soft  and  hard  tissues,  conventional 
mechanical  debridement  and  good  oral  hy-
giene may accomplish a temporary decrease of 
microorganisms  in  dental  plaques  [5].  To 
overcome these problems, it is essential to de-
velop new antimicrobial therapic approaches. 
Recently, vaccines for dental caries and peri-
odontal diseases have been produced and ap-
plied on patients [6-7].One alternative method 
is photodynamic therapy (PDT), showing great 
potential  for  the  treatment  of  neoplastic  and 
non-neoplastic  diseases  which  was  firstly 
demonstrated by Jodlbauer and von Tappeiner 
in  1904  [8-9].  In  this  method,  a  photoactive 
dye, termed a photosensitizer [PS] is taken up 
into the cells and is then irradiated with light 
of an appropriate wavelength. This may end in 
cell  death  through  the  production  of  active 
oxygen  molecules  [10].  Generally,  in  photo-
sensitization processes, the laser or PS alone 
are not toxic [11] and only cells that contain 
the photosensitizer and also receive laser are 
affected by the treatment finally. Thus, the use 
of  this  method  provides  an  opportunity  to 
achieve selectivity and to target specific sites 
of the mouth or the plaque [12]. Antibacterial 
photosensitizers  currently  under  investigation 
for use in the mouth include TBO and chlorin 
e6 [13-14]. These agents show great promise, 
but  will  necessarily  be  subjected  to  lengthy 
experimental  and  clinical  assessments.  How-
ever, more benefits could be derived from pho-
tosensitizers  recently  certified  for  oral  use. 
One  such  photosensitizer  is  Radachlorin® 
which is a chlorophyll a derivative, including 
mainly  sodium  chlorin  e6,  having  been  suc-
cessfully  applied  in  diagnosing  tumors  and 
treating surface tumors [15].  
There have been only a few studies on the an-
timicrobial  photodynamic  therapic  (APDT) 
effects of Radachlorin®, although there have 
been several studies on chlorin e6, which is a 
major component of Radachlorin® [14,16]. On 
the other hand, TBO is a widely known photo-
sensitizer that has been in use for many years 
and  is  efficient  in  producing  singlet  oxygen 
under the maximum absorption wavelength of 
630 nm. TBO has also been reported as an ef-
fective  dye  for  inactivation  of  yeasts,  gram 
positive  and  gram  negative  bacteria  in  assis-
tance with laser irradiation [17-19]. Therefore, 
this prompted us to carry out an in vitro study 
on  the  subject  of  the  antimicrobial  photody-
namic  effect  of  Radachlorin®  in  comparison 
with  TBO  on  the  viability  of  Streptococcus 
mutans to enhance PDT application in plaque-
related disease treatment. 
 
MATERIALS AND METHODS 
Bacterial  culture:  The  standard  strain  of 
Streptococcus  mutans  (ATCC  35668,  PTCC 
1683) was purchased from the Iranian Science 
Organization  of  Science  and  Technology 
(IROST) in Tehran, Iran.  
The bacterium was subcultured on mitis sali-
various agar (Quelab, Canada) and then incu-
bated at 37°C in the presence of 10% CO2 for 
24 hours. Overnight cultures were prepared in 
Trypticase  Soy  Broth  (Merk,  Germany)  by 
transferring a few colonies grown on mitis sa-
livarious agar. The bacterial suspensions were 
then diluted in broth to an optical density of 
McFarland  No:  0.5  (approximate  numbers 
1.5×10
8 bacteria mL
-1). 
 
Photosensitizers and laser sources: Radach-
lorin®  gel  (0.1%,  25  g)  was  obtained  from 
RADA-FARMA Ltd, Russia and stored at 0-8 
°C in the dark (Fig 1).  
Toluidine  blue  powder  was  taken  from  Mi-
cromedia chemicals-Hungry, dissolved in ste-
rile saline firstly to reach the final concentra-
tion of 0.1% and then subsequently kept in the 
dark (Fig 2). 
The laser sources used for each photosensitizer 
were a diode laser (Milon-LAHTA, Russia)  
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(Fig  3)  with  a  fiber  optic  diameter  of  800
micrometer, a maximum output of 2.5 W and a 
predominant  wavelength  of  662  nm  for  R
dachlorin® and the irradiation of a diode laser 
(Mustang 2000, Moscow, Russia) (Fig 4) 
a hand held probe of KLO4 and a maximum
power  output  of  30  mW  at  a  wavelength  of 
633  nm  for  TBO.  The  distance  between  the 
laser tips and the illuminated area was adjusted 
to create a spot light of 1 cm in diameter with 
a fixed power density for each photosensitiz
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for  Radachlorin®  and  30  mW/cm
and continuous mode for toluidine blue O.
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30  mW/cm
2,  3  J/cm
2 
and continuous mode for toluidine blue O. 
The concentration of 0.2 ml of each photosen-
sitizer was applied on 0.2 ml of the bacterial 
suspensions. The following groups were used: 
(no laser, no photosensitizer), (II) L
-  
(treated only with PS), (III) L
+ PS
- (treated 
only with laser) and (IV) L
+ PS
+ (treated with 
laser  and  PS:  photodynamic  therapy  group). 
Group I and II were kept in the incubator at 
C in the presence of 10% CO2.  
Bacterial  suspensions  in  group  III  and  espe-
cially group IV which were incubated with PS 
for 10 minutes in the dark at room tempera-
ture, were exposed to 662 and 633 nm laser 
from  above  for  120  and  150  seconds  in  the 
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dark  at  room  temperature  and  subsequently 
transferred  to  the  incubator.  After  overnight 
incubation of all groups, they were cultured on 
mitis salivarious agar and viable microorgan-
isms grown on the plates were counted in the 
next day. 
 
Statistical analysis: In order to access the dif-
ferences between the groups, the variable bac-
terium reduction promoted by each treatment 
was  analyzed  by  Kruskal-Wallis  and  Mann-
Whitney  U  test.  Statistical  significance  was 
accepted at p<0.05. The Statistical Package for 
Social  Sciences  (SPSS)16  for  Windows, 
(SPSS  Inc,  Chicago,  IL,  USA)  was  used  for 
data analysis. 
 
DISCUSSION 
 The  growing  bacterial  resistance  in  spite  of 
antibiotic drugs, conventional mechanical de-
bridement and chemical agents has questioned 
the efficiency of these therapies. To overcome 
these problems, photodynamic therapy has be-
come a possible alternative antibacterial thera-
py for plaque-related diseases such as dental 
caries. The advantages of PDT over conven-
tional  antimicrobial  agents  are  non-invasive 
nature, ease of reaching deeply situated areas, 
repeatability, high selectivity, no resistance to 
drugs,  rapid killing of target microorganisms 
in  a  few  minutes  depending  mainly  on  the 
energy densities delivered (on the contrary, in 
conventional  antimicrobial  agents  hours  or 
even days are necessary) and finally that anti-
microbial effects may be limited to the site of 
the  lesion  by  careful  topical  application  of 
photosensitizers and the site of irradiation may 
even be restricted further by using an optical 
fiber [21-22]. In fact, in the human oral cavity, 
there are very large numbers of bacterial spe-
cies,  which  comprise  a  complex  ecosystem. 
Thus, the response of the bacterial community 
to photodynamic treatment may differ greatly 
from that of their in vitro cultured isolates in 
many aspects, such as growth rate, metabolic 
activity  and  gene  expression  [23-24].  Wain-
wright  also  demonstrated  that  photodynamic 
inactivation (PDI) of microorganisms depends 
on the chemical structure of PS and the incu-
bation time of the drug with the bacterial cells. 
Damage  to  the  bacterial  cell  wall,  increased 
permeability  of  cytoplasmic  membrane  and 
nucleic acid strand breakage may be resulted 
following with PDI [25]. Based on these ad-
vantages, several studies were carried out us-
ing PDT approving that oral bacteria are sus-
ceptible to PDT [26-27]. Photosensitizers are 
vital  elements  in  PDT;  several  studies  have 
demonstrated the efficacy of a range of photo-
sensitizers  in  the  elimination  or  reduction  of 
oral bacteria [11,28-29]. TBO is an attractive 
option  because  of  its  affordable  cost  and  in-
tense  absorption  wavelength  in  the  red  light 
spectrum  (>  600  nm)  [30],  while  Radachlo-
rin®  is  a  chlorophyll  a  derivative,  including 
mainly sodium chlorin e6, which has already 
passed  complete  pre-clinical  assessments. 
These clinical trials have clarified significant 
advantages;  such  as  very  low  toxicity  in  the 
dark,  high  contrast  of  tumor  accumulation, 
much more rapid body  evacuation (only two 
days), intensive absorption band at relatively 
large  wavelengths  where  tissues  are  more 
transparent and finally the high phototoxicity 
[15,31].  Soukos,  Rovaldi  and  Pfitzner  deter-
mined the antimicrobial activity of chlorin e6 
derivatives like Poly-L-Lysine chlorin e6 con-
jugates  and  new  photosensitizer  BLC1010, 
BLC  1014  on  anaerobic  bacteria  compared 
with pure chlorin e6 [14,32,33]. Risovannaia 
also  reported  that  Radachlorin®-mediated 
photodynamic  therapy  could  eliminate  Strep-
tococcus pyogens in the animals infected tis-
sues  [34].  The  results  obtained  in  this  study 
demonstrated  that  TBO-mediated  photody-
namic therapy was more successful compared 
to Radachlorin® in effective bacterial reduc-
tion. The most effective combination is 0.1% 
TBO with 3 J/cm
2 laser at 30 mW. Our find-
ings  regarding  TBO  are  in  accordance  with The Effect of Antimicrobial Photodynamic Therapy... 
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those previous studies which have shown that 
it is possible to kill periodontal bacteria by us-
ing  low  concentration  of  toluidine  blue  and 
low  energy  densities  [35-37].  Although  the 
bacterial count reduction in 3 J/cm
2 laser irrad-
iation alone was more than our expectation, it 
may  be  explained  by  attenuation  in  bacterial 
growth as fastidious microorganism. One ex-
planation for the decreased photodynamic ef-
fect  of  Radachlorin®  may  be  that  extra  Ra-
dachlorin® molecules which could not bond to 
the  bacterium  excessively  spend  the  limited 
oxygen molecules dissolved in the suspension 
and  would  reduce  available  oxygen  for  the 
photosensitizer molecules inside or close to the 
bacterium.  
Another explanation may be defined according 
to Wainwright’s study which was carried out 
on fotolon as a major component of Radachlo-
rin® indicating that high power density over a 
short  time  period  may  give  different  antimi-
crobial effects in comparison with lower pow-
er  density  over  a  longer  time  even  with  the 
same energy density in both cases.  
He also declared that the reduced photobleach-
ing rates for higher chlorin e6 concentrations 
may be explained by the self-shielding effect. 
In a higher concentration of the dye, the dis-
tance traveled by the excitation light may be 
reduced due to its loss in intensity. In such a 
case, superficial layers of the dye absorb the 
laser very efficiently, but they prevent its pe-
netration into deeper layers.  
Finally,  the  photobleached  superficial  layers 
become  transparent  while  deeper  layers  still 
strongly absorb the laser.  
This  is  why  radiant  exposures  for  a  highly 
concentrated  photosensitizer  may  be  under-
rated, leading to reduced PDI efficiency. Dur-
ing  the  antibacterial  experiments,  the  energy 
density of 15 J/cm
2 under 60 sec illumination 
could  not  completely  photobleach  chlorin  e6 
solution and in fact, a higher dose (such as a 
dose higher than 30 J/cm
2) should be used for 
further enhancement of PDI [25].  
CONCLUSION 
In conclusion, our results demonstrate that the 
association of TBO with a diode laser and the 
energy density of 3 J/cm
2 may be more effec-
tive in reducing the viability of streptococcus 
mutans pure cultures compared with Radach-
lorin®-mediated 12 J/cm
2 laser irradiation. 
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